Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.

Abstract

BACKGROUND Chronic hepatitis B infection carries considerable risk for the development of cirrhosis and hepatocellular carcinoma. Treatment options are increasing but are limited to interferon alfa-2b, pegylated interferon alfa-2a, lamivudine, adefovir dipivoxil, and entecavir. Entecavir, a nucleoside analog, is the newest oral antiviral approved in the… (More)

Topics

Cite this paper

@article{Sims2006EntecavirAN, title={Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.}, author={Keri A Sims and Abigail M Woodland}, journal={Pharmacotherapy}, year={2006}, volume={26 12}, pages={1745-57} }